Company: DNLI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001714899-25-000193
Chunk: 418

Company: Denali Therapeutics Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 418
---
4, respectively. Finance lease costs representing amortization of ROU assets and interest on lease liability were $0.9 million and $0.2 million, respectively, for the three months ended September 30, 2025, and $2.7 million and $0.5 million, respectively, for the nine months ended September 30, 2025. Finance lease costs representing amortization of ROU assets and interest on lease liability were $0.4 million and $0.1 million, respectively, for both the three and nine months ended September 30, 2024.The following tables contain a summary of other information pertaining to the Company’s leases for the periods presented (in thousands):Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Operating cash flows from operating lease$2,980 $2,885 $8,813 $8,532 As of September 30,20252024Weighted-average remaining lease term (in years):Operating lease3.6 years4.6 yearsFinance lease13.5 years14.5 yearsWeighted-average discount rate applied (%):Operating lease9.0%9.0%Finance lease13.7%13.7%

16

The following table reconciles the undiscounted cash flows for the next five years and total of the remaining years to the operating and finance lease liabilities recorded in the Condensed Consolidated Balance Sheet as of September 30, 2025 (in thousands):Year Ended December 31:Operating LeaseFinance Lease2025 (three months)$2,980 $195 202612,182 794 202712,584 811 202813,001 829 20294,381 848 Thereafter— 8,814 Total undiscounted lease payments45,128 12,291 Less: present value adjustment(6,278)— Less: imputed interest— (6,661)Total future minimum lease payments$38,850 $5,630 

IndemnificationIn the ordinary course of business, the Company may provide indemnifications of varying scope and terms to vendors, lessors, business partners, board members, officers, and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, services to be provided by the Company, negligence or willful misconduct of the Company, violations of law by the Company, or from intellectual property infringement claims